| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | Director | Common Shares | 74.2K | $731K | $9.85 | Dec 19, 2023 | Direct |
| LISATA THERAPEUTICS, INC. | Director | Common Stock | 58.7K | $175K | $2.99 | Jan 9, 2024 | Direct |
| DURECT CORP | Director | Stock Option (right to buy) | 5.5K | Sep 25, 2024 | Direct | ||
| Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | Dec 19, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DRRX | DURECT CORP | Sep 25, 2024 | 1 | $0 | 4 | Sep 27, 2024 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2024 | 1 | $0 | 4 | Jan 11, 2024 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Dec 19, 2023 | 4 | $42.6K | 4 | Dec 20, 2023 | Director |
| DRRX | DURECT CORP | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Dec 12, 2022 | 2 | $8.27K | 4 | Dec 13, 2022 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Sep 15, 2022 | 1 | $120K | 4 | Sep 16, 2022 | Director |
| LSTA | LISATA THERAPEUTICS, INC. | Sep 15, 2022 | 0 | $0 | 3 | Sep 16, 2022 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| DRRX | DURECT CORP | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| DRRX | DURECT CORP | May 24, 2022 | 5 | $11.6K | 4 | May 25, 2022 | Director |
| DRRX | DURECT CORP | May 16, 2022 | 4 | $12.2K | 4 | May 18, 2022 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Dec 15, 2021 | 2 | $11.3K | 4 | Dec 17, 2021 | Director |
| DRRX | DURECT CORP | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| XENE | Xenon Pharmaceuticals Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |